Abstract: For years, global genetic databases have missed the unique details of smaller populations, making it harder to diagnose diseases in specific regions. The biobank.cy Center of Excellence is changing this by creating a national “genetic map” of Cyprus. By studying over 12,000 volunteers, researchers are building a reference genome that helps doctors distinguish normal local diversity from actual disease-causing mutations. This work is the essential first step toward personalized medicine, ensuring that healthcare in Cyprus is based on the island’s own DNA rather than a one-size-fits-all global average.
The results from the CYPROME project are already saving lives by identifying “actionable” genetic variants. Researchers found that 5% of participants carry DNA changes linked to conditions like heart disease and hereditary cancers, many of which are unique to or enriched in the Cypriot population. Because these variants are “actionable,” it means doctors can offer early monitoring or preventive treatments before a patient even gets sick. This transition from reactive to proactive medicine shows that biobanking is not just about data; it is a powerful shield for public health.
Get this full article here: https://sciencebusiness.net/news/mapping-cyprus-dna
